EE9600180A - Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine - Google Patents
Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamineInfo
- Publication number
- EE9600180A EE9600180A EE9600180A EE9600180A EE9600180A EE 9600180 A EE9600180 A EE 9600180A EE 9600180 A EE9600180 A EE 9600180A EE 9600180 A EE9600180 A EE 9600180A EE 9600180 A EE9600180 A EE 9600180A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- hiv composition
- hiv
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94201897 | 1994-07-01 | ||
| PCT/EP1995/002462 WO1996001110A2 (en) | 1994-07-01 | 1995-06-23 | Anti-hiv triple combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9600180A true EE9600180A (et) | 1997-06-16 |
Family
ID=8217000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9600180A EE9600180A (et) | 1994-07-01 | 1995-06-23 | Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0768881B1 (et) |
| JP (1) | JP2945481B2 (et) |
| KR (1) | KR100218495B1 (et) |
| CN (1) | CN1091599C (et) |
| AP (1) | AP9600896A0 (et) |
| AT (1) | ATE218867T1 (et) |
| AU (1) | AU693911B2 (et) |
| BG (1) | BG101175A (et) |
| BR (1) | BR9508201A (et) |
| CA (1) | CA2193489A1 (et) |
| CZ (1) | CZ375596A3 (et) |
| DE (1) | DE69527066T2 (et) |
| EE (1) | EE9600180A (et) |
| FI (1) | FI965292A0 (et) |
| HU (1) | HUT77720A (et) |
| IL (1) | IL114415A0 (et) |
| MX (1) | MX9700044A (et) |
| MY (1) | MY130597A (et) |
| NO (1) | NO965556L (et) |
| OA (1) | OA10341A (et) |
| PL (1) | PL317891A1 (et) |
| SK (1) | SK168196A3 (et) |
| TW (1) | TW401303B (et) |
| WO (1) | WO1996001110A2 (et) |
| ZA (1) | ZA955471B (et) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008539A1 (en) * | 1996-08-26 | 1998-03-05 | Chiron Corporation | Postinfection human immunodeficiency virus (hiv) vaccination therapy |
| EP0872233A1 (en) * | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
| PT1225874E (pt) | 1999-09-24 | 2006-06-30 | Janssen Pharmaceutica Nv | Composicoes antivirais. |
| MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
| US9044509B2 (en) | 2006-02-03 | 2015-06-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibition of HIV infection through chemoprophylaxis |
| CL2008000746A1 (es) | 2007-03-14 | 2008-09-22 | Tibotec Pharm Ltd | Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida. |
| WO2010137027A1 (en) | 2009-05-27 | 2010-12-02 | Hetero Research Foundation | Solid oral dosage forms of lamivudine |
| US20210128554A1 (en) * | 2016-12-23 | 2021-05-06 | Temple University - Of The Commonwealth System Of Higher Education | Anti-flaviviridae activity of anti-retroviral non-nucleoside (nnrtis) and nucleoside reverse transcriptase inhibitors (nnrtis) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992020344A1 (en) * | 1991-05-16 | 1992-11-26 | Glaxo Group Limited | Antiviral combinations containing nucleoside analogs |
-
1994
- 1994-05-25 TW TW084105260A patent/TW401303B/zh active
-
1995
- 1995-06-23 EE EE9600180A patent/EE9600180A/et unknown
- 1995-06-23 EP EP95924930A patent/EP0768881B1/en not_active Expired - Lifetime
- 1995-06-23 CN CN95193943A patent/CN1091599C/zh not_active Expired - Fee Related
- 1995-06-23 AU AU29248/95A patent/AU693911B2/en not_active Ceased
- 1995-06-23 WO PCT/EP1995/002462 patent/WO1996001110A2/en active IP Right Grant
- 1995-06-23 AT AT95924930T patent/ATE218867T1/de not_active IP Right Cessation
- 1995-06-23 SK SK1681-96A patent/SK168196A3/sk unknown
- 1995-06-23 JP JP8503654A patent/JP2945481B2/ja not_active Expired - Fee Related
- 1995-06-23 BR BR9508201A patent/BR9508201A/pt not_active Application Discontinuation
- 1995-06-23 MX MX9700044A patent/MX9700044A/es unknown
- 1995-06-23 DE DE69527066T patent/DE69527066T2/de not_active Expired - Fee Related
- 1995-06-23 CZ CZ963755A patent/CZ375596A3/cs unknown
- 1995-06-23 PL PL95317891A patent/PL317891A1/xx unknown
- 1995-06-23 CA CA002193489A patent/CA2193489A1/en not_active Abandoned
- 1995-06-23 AP APAP/P/1996/000896A patent/AP9600896A0/en unknown
- 1995-06-23 HU HU9603627A patent/HUT77720A/hu unknown
- 1995-06-30 MY MYPI95001822A patent/MY130597A/en unknown
- 1995-06-30 IL IL11441595A patent/IL114415A0/xx unknown
- 1995-06-30 ZA ZA955471A patent/ZA955471B/xx unknown
-
1996
- 1996-12-23 NO NO965556A patent/NO965556L/no unknown
- 1996-12-27 KR KR1019960707474A patent/KR100218495B1/ko not_active IP Right Cessation
- 1996-12-31 OA OA60946A patent/OA10341A/en unknown
- 1996-12-31 FI FI965292A patent/FI965292A0/fi not_active Application Discontinuation
-
1997
- 1997-01-27 BG BG101175A patent/BG101175A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA955471B (en) | 1996-12-30 |
| AU2924895A (en) | 1996-01-25 |
| HUT77720A (hu) | 1998-07-28 |
| WO1996001110A3 (en) | 1996-02-22 |
| BR9508201A (pt) | 1997-11-11 |
| DE69527066T2 (de) | 2003-02-13 |
| CA2193489A1 (en) | 1996-01-18 |
| FI965292A (fi) | 1996-12-31 |
| FI965292A0 (fi) | 1996-12-31 |
| AP9600896A0 (en) | 1997-01-31 |
| SK168196A3 (en) | 1997-05-07 |
| CN1151697A (zh) | 1997-06-11 |
| EP0768881B1 (en) | 2002-06-12 |
| WO1996001110A2 (en) | 1996-01-18 |
| JP2945481B2 (ja) | 1999-09-06 |
| BG101175A (en) | 1997-08-29 |
| CN1091599C (zh) | 2002-10-02 |
| NO965556D0 (no) | 1996-12-23 |
| ATE218867T1 (de) | 2002-06-15 |
| JPH09507858A (ja) | 1997-08-12 |
| AU693911B2 (en) | 1998-07-09 |
| TW401303B (en) | 2000-08-11 |
| MY130597A (en) | 2007-07-31 |
| EP0768881A2 (en) | 1997-04-23 |
| KR100218495B1 (en) | 1999-09-01 |
| HU9603627D0 (en) | 1997-02-28 |
| IL114415A0 (en) | 1995-10-31 |
| DE69527066D1 (de) | 2002-07-18 |
| OA10341A (en) | 1997-10-07 |
| PL317891A1 (en) | 1997-04-28 |
| NO965556L (no) | 1996-12-23 |
| CZ375596A3 (en) | 1997-04-16 |
| MX9700044A (es) | 1997-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03338B1 (et) | Tromboosivastane ravim, selle valmistamise protsess ja kasutamine | |
| EE9700310A (et) | N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine | |
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| FI955235A0 (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
| EE9800136A (et) | Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine | |
| EE03409B1 (et) | Kõrge efektiivsusega segusti ja selle valmistamise meetod | |
| EE03528B1 (et) | Valatsükloviirvesinikkloriid, selle valmistamismeetod ja kasutamine | |
| EE05214B1 (et) | Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon | |
| EE03676B1 (et) | Mullpakend, selle valmistamise meetod ja mullpakendi kasutamine | |
| EE9900147A (et) | Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena | |
| BR9708400A (pt) | Composição sua preparação e uso | |
| FI902106A0 (fi) | Plastoelastisia polypropyleenikoostumuksia, niiden valmistus ja käyttö | |
| EE9900014A (et) | Erütromütsiinid ja nende valmistamise protsess | |
| FI103704B1 (fi) | Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö | |
| EE03568B1 (et) | Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine | |
| EE03825B1 (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| EE9800200A (et) | Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| EE200100314A (et) | Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine | |
| EE03554B1 (et) | Mikropoorne kristalne materjal, selle valmistamismeetod ja kasutamine detergentkompositsioonides | |
| EE200000099A (et) | Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode | |
| FI944182A0 (fi) | Yhtenäiskiteitä sisältävä koostumus, menetelmä senYhtenäiskiteitä sisältävä koostumus, menetelmä sen valmistamiseksi ja sen käyttö valmistamiseksi ja sen käyttö | |
| EE9600180A (et) | Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| FI941914A (fi) | 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö |